PARP1 and familial pancreatic carcinoma: A previous study has indicated that DSF combined with chemotherapy activates the cGAS-STING pathway in pancreatic cancer cells by inhibiting PARP1 activity; however, DSF alone showed no effect on enhancing IFNB1 expression 58.